ARCHIVES

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

AIDS Commission Asks, “Give Us A Chance”

September 18, 1987

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

March 26, 1976

President Asks ‘Standstill’ FY 1976 Budget For NCI, $123 Million Slash From ’75 Spending

February 7, 1975

Breast Implants Lessen Ability Of Mammograms To Find Cancer

February 27, 2004

NCI Workshop Summary “Incomplete,” Kopans Writes In Letter

April 16, 1993

Exit Joseph Nevins: Duke’s Genomics Luminary Quietly Leaves

October 18, 2013